SEC Form 4 · accession 0001209191-16-136406
Viridian Therapeutics, Inc.\DE · VRDN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tamara A Seymour
Officer — CFO, Secretary, Treasurer
Period of report
Aug 8, 2016
Accepted (ET)
Aug 10, 2016 · 6:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590750
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 8, 2016 | M | 23,000 | — | A | 37,478 | I | By Trust |
| Common StockF2 | Aug 8, 2016 | F | 10,484 | $0.485 | D | 26,994 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Aug 8, 2016 | M | 23,000 | D | — | — | Common Stock | 23,000 | 46,000 | D |
Explanation of responses
- F1Restricted stock units converted into common stock on a one-for-one basis.
- F2Shares withheld to satisfy tax withholding obligations.
- F3On August 4, 2014 the reporting person was granted 92,000 restricted stock units. Under the terms of the restricted stock unit agreement, 23,000 shares vested on each of August 4, 2015 and August 4, 2016 and the remainder shares will vest in two equal installments on each of August 4, 2017 and August 4, 2018. The shares being reported herein were settled on August 8, 2016.